Ligand Pharmaceuticals, Inc. (LGND)

189.07 -1.13 (-0.59%) USD  |  NASDAQ  |  Dec 31, 16:00
188.93 -0.14 (-0.07%) After-Hours: 20:00
More

Ligand Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for LGND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Johnson & Johnson Upgrade
Inspire Medical Systems, Inc. Upgrade
Elanco Animal Health, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade